Keywords: Santaris Pharma. Isis Pharma, US patents, Antisense molecules

Santaris prevails in patent battle with Isis Pharma

Article | 30 November 2011

Denmark-based RNA-targeted therapies developer Santaris Pharma A/S says that it has won two significant patent re-examination cases brought by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Santaris Pharma

Isis Pharmaceuticals

Go to company listing